Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.
about
Active surveillance and focal therapy for low-intermediate risk prostate cancerThe current and future role of magnetic resonance imaging in prostate cancer detection and managementOverdiagnosis and overtreatment of prostate cancerMultifocal epithelial tumors and field cancerization: stroma as a primary determinantThe ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancerCancer Immunoprevention and Public Health.Prostate cancer risk profiles of Asian-American men: disentangling the effects of immigration status and race/ethnicityThe high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era.Conceptualizing overdiagnosis in cancer screeningNanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept studyLifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008-2010Screening for familial and hereditary prostate cancer.A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.A Perspective on Prostate Carcinogenesis and ChemopreventionRandomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.Prevalence of incidental prostate cancer: A systematic review of autopsy studies.Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation.Childhood height and birth weight in relation to future prostate cancer risk: a cohort study based on the copenhagen school health records register.Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies.Management of low risk prostate cancer-active surveillance and focal therapy.Controversies associated with the evaluation of elderly men with localized prostate cancer when considering radical prostatectomy.Prospective study of DNA methylation at chromosome 8q24 in peripheral blood and prostate cancer risk.Active Surveillance for Intermediate Risk Prostate Cancer.Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.Is There a Future for Chemoprevention of Prostate Cancer?A key to the backdoor into the castle: The clinical ramifications of immunoediting driven by antigenic competitionRole of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancerIncidence of intraductal carcinoma, multifocality and bilateral significant disease in radical prostatectomy specimens from Japan and United States.Chemoprevention in African American Men With Prostate Cancer.Validation of active surveillance criteria for pathologically insignificant prostate cancer in Asian men.Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study.Testosterone inhibits the growth of prostate cancer xenografts in nude mice.Is it appropriate to conduct conventional active surveillance for Asian men with low-risk prostate cancer?Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry.Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer.
P2860
Q26773641-62F6DD16-EC81-44C4-B5B9-2BF14764DB13Q26773645-3D4F21D4-FCE3-48AA-BAA0-1039A974E4EEQ26859596-965D2DD0-B202-4C7C-AD01-F6AA284C6FCEQ27005678-8CDC23AC-13E7-468E-94E4-AFAFCA61A3AEQ30641961-AE62A87F-E9CD-4281-ACF9-316062F44914Q33599365-ABA54E80-9D11-4237-9018-19E16F18AE40Q33646584-B5DBA6C3-19AF-4BF0-804A-7FD42A9F21D1Q33733335-280E8467-2D89-47FD-9750-E7CD0C3FCFC6Q34042937-ECDB8D38-F7D4-4278-BDCB-DCBF704618EFQ35102637-1878EAA4-70D0-4A35-839A-E08CAC175470Q35112929-7EFCB8D7-11D4-43D1-A3C5-13AFA488CF6DQ35724984-891700EA-1197-4A08-944C-AF559E98059DQ35861576-94087BF3-FE6C-44F1-A1C0-02D63DC96EFDQ36049662-7FB4E34B-E501-40FE-887B-53334099E918Q36051375-225FFACA-C3B8-42B3-B6CC-C1A95D25CD1EQ36116269-A613B888-022F-46C2-965B-B86834EB32D1Q36132629-378E4DF2-B3CE-49EA-955B-FE6BEE66E1F6Q36380194-DE4B37D6-1233-4C5C-9F8B-A40933F098AFQ36639217-668C4141-3165-4D29-A295-805487511909Q37086267-D0AB402C-0143-4E91-BC55-D6880DD7E7D2Q37393721-C4F6BB9D-F8F4-4236-9012-401EF9D162E5Q38204779-0140D557-1E6B-4608-8238-363ABD3FB6F3Q38211360-E97CCC75-F604-4504-A137-5F18BB66DE3EQ38242745-ED4937A0-4E98-4414-91FD-35D1CB0B20FAQ38371012-AA519588-8AAF-4502-A48E-74D644DBFA19Q38627996-02147981-0A39-4A5C-B17F-C312E996D2C2Q38855675-F2DF8FE8-E2F5-4CA5-9223-7A58B481B0B0Q38878301-CA241F17-5388-4B81-B047-7AB95E4D045EQ38878374-F2CF2BF1-2FB9-4923-99F9-ED3B8F1DBCDCQ38925342-2EE22D27-EE07-4516-B2D0-29BF222B03C5Q39211272-A84D7712-9228-47B2-95EB-09D4338B7282Q39245025-53AC5FAE-D49C-4441-BB1E-8CFFAD4FC8A1Q40420426-17B9F920-43B2-41CE-9742-BAC05CB21932Q40450047-C11CA739-737D-4C68-BD82-72DB331B7FFCQ40875442-CA17C2C8-8E65-4D74-8DC3-CFA20CE504DBQ41329517-4668151E-DE1E-44D2-81E1-96F97272DBD9Q41589981-84AB39C7-EC08-453A-8C5C-3921ECDE04FFQ45287773-EC614983-D337-4307-AD01-1FBECFA1361FQ47692316-BAE797DA-79A9-4254-838C-4E84C4FA4658Q49038959-C82F5024-2FF7-401A-8D29-779690EE422B
P2860
Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prevalence of prostate cancer ...... eened Caucasian and Asian men.
@en
Prevalence of prostate cancer ...... eened Caucasian and Asian men.
@nl
type
label
Prevalence of prostate cancer ...... eened Caucasian and Asian men.
@en
Prevalence of prostate cancer ...... eened Caucasian and Asian men.
@nl
prefLabel
Prevalence of prostate cancer ...... eened Caucasian and Asian men.
@en
Prevalence of prostate cancer ...... eened Caucasian and Asian men.
@nl
P2093
P2860
P50
P356
P1476
Prevalence of prostate cancer ...... eened Caucasian and Asian men.
@en
P2093
Alexander Govorov
Alexandre R Zlotta
Antonio Finelli
Cynthia Kuk
Gina Lockwood
Hiroyuki Takahashi
Jenna Sykes
Marta Kovylina
Masahito Kido
Neil Fleshner
P2860
P304
P356
10.1093/JNCI/DJT151
P407
P577
2013-07-11T00:00:00Z